BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 15340387)

  • 1. The endocannabinoid system and its therapeutic exploitation.
    Di Marzo V; Bifulco M; De Petrocellis L
    Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system: a drug discovery perspective.
    Piomelli D
    Curr Opin Investig Drugs; 2005 Jul; 6(7):672-9. PubMed ID: 16044662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid signalling system: biochemical aspects.
    Bisogno T; Ligresti A; Di Marzo V
    Pharmacol Biochem Behav; 2005 Jun; 81(2):224-38. PubMed ID: 15935454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional organization ant therapeutic potential of the endogenous cannabinoid system].
    Churiukanov MV; Churiukanov VV
    Eksp Klin Farmakol; 2004; 67(2):70-8. PubMed ID: 15188768
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S; Gertsch J
    J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
    Bifulco M; Laezza C; Gazzerro P; Pentimalli F
    Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
    Bifulco M; Di Marzo V
    Recenti Prog Med; 2003 May; 94(5):194-8. PubMed ID: 12723496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K; Goś R
    Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids and atherosclerosis.
    Fisar Z
    Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors: where they are and what they do.
    Mackie K
    J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology and systems physiology of the endocannabinoid system.
    Wegener N; Koch M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S79-86. PubMed ID: 19434559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic neuroanatomy and neuropharmacology of cannabinoids.
    Breivogel CS; Sim-Selley LJ
    Int Rev Psychiatry; 2009 Apr; 21(2):113-21. PubMed ID: 19367505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The modulatory role of endocannabinoids in sleep].
    Murillo-Rodríguez E
    Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid chemical biology: a tool for the development of novel therapies.
    Petrosino S; Ligresti A; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):309-20. PubMed ID: 19457702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.